At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Non-Interventionalother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Role of Interleukin 5 (IL-5) and IL-5R Signaling in Non-eosinophil Upper Airway Cells in Chronic Rhinosinusitis With Nasal Polyps
In Brief
An observational study evaluating Non-Interventional for Nasal Polyps and Aspirin-exacerbated Respiratory Disease. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The overarching hypothesis of this proposal is that IL-5 acts on multiple sinus tissue cell types, including plasma cells and epithelial cells, to promote immune dysregulation, and that inhibition of IL-5 affects several relevant effector pathways that lead to clinical benefit.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartOct 2022
First PostedJan 2023
Primary CompletionDec 2023
TodayJul 2026
First PostedJan 5, 2023
Enrollment StartOct 1, 2022
Primary CompletionDec 1, 2023
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 3.5 years ago
Interventions
Non-Interventionalother
No intervention.